Loading…

The Effect of Glutathione as an Adjuvant Therapy for Skin Whitening and Hyperpigmentation in Type 2 Diabetes

Background: Glutathione (GSH) used for skin lightening can also affect Glucose metabolism in diabetics because of its antioxidant properties. This study aimed to determine the effects of systemic glutathione on various parameters in type 2 diabetes. Methods: It was an interventional study (open labe...

Full description

Saved in:
Bibliographic Details
Published in:Pakistan journal of medicine and dentistry 2024-05, Vol.10 (4)
Main Authors: Madiha Soban, Iftikhar Ahmed, Navaid Siddiqui, Faisal Ahmed, Ashar fawad, Tahira Assad Shaikh
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 4
container_start_page
container_title Pakistan journal of medicine and dentistry
container_volume 10
creator Madiha Soban
Iftikhar Ahmed
Navaid Siddiqui
Faisal Ahmed
Ashar fawad
Tahira Assad Shaikh
description Background: Glutathione (GSH) used for skin lightening can also affect Glucose metabolism in diabetics because of its antioxidant properties. This study aimed to determine the effects of systemic glutathione on various parameters in type 2 diabetes. Methods: It was an interventional study (open label trial) conducted at Skin care clinic and Baqai Institute of Diabetes and Endocrinology from August 2019 to January 2020. Total patients included in this study were 46 who met the inclusion criteria along with 20 participants as controls. Oral Glutathione (500 mg B.D) was given to both groups for 18 weeks. Pre and post treatment Plasma Glutathione, fasting blood sugar (FBS), random blood sugar (RBS), and HbA1c levels were evaluated. Taylor hyperpigmentation scale was used to measure skin tone. BMI and Anthropometric measurements were also measured. Paired t-test/dependent t-test and Chi squared test was performed and p < 0.05 was considered statistically significant. Results: Oral Glutathione caused significant reduction in FBS, RBS and HbA1c levels in type 2 diabetics. Mean values of both random and fasting blood sugar significantly decreased in patients group. RBS decreased from 232±10.04 mg/dl to 178±10.37 mg/dl (
doi_str_mv 10.36283/PJMD10-4/004
format article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c3b1f00d7d014cfba11baa5685e42fdd</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c3b1f00d7d014cfba11baa5685e42fdd</doaj_id><sourcerecordid>oai_doaj_org_article_c3b1f00d7d014cfba11baa5685e42fdd</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1434-500e65bd52b265408eebd01ba7515a98a6e6ad80df566f587b2310eb90964da23</originalsourceid><addsrcrecordid>eNo9kE9LAzEQxRdRsGiP3vMF1k42f3Z7LG2tiqJgxWOYbCZtartbsqvQb29sxdM8Ho_fY16W3XC4FbqoxOj18XnGIZcjAHmWDQoBVV6osTj_1VzkpSj5ZTbsug0ACAFlJfQg2y7XxObeU92z1rPF9qvHfh3ahhh2DBs2cZuvb2x6loIR9wfm28jePkPDPtahpyY0qxRz7P6wp7gPqx01iZAALEWWyWQFmwW01FN3nV143HY0_LtX2fvdfDm9z59eFg_TyVNecylkrgBIK-tUYQutJFRE1gG3WCqucFyhJo2uAueV1l5VpU0PAtkxjLV0WIir7OHEdS1uzD6GHcaDaTGYo9HGlcHYh3pLphaWewBXpgJZe4s89aDSlSJZeOcSKz-x6th2XST_z-Ngjsub0_JGmrS8-AFCe3Yp</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Effect of Glutathione as an Adjuvant Therapy for Skin Whitening and Hyperpigmentation in Type 2 Diabetes</title><source>DOAJ Directory of Open Access Journals</source><creator>Madiha Soban ; Iftikhar Ahmed ; Navaid Siddiqui ; Faisal Ahmed ; Ashar fawad ; Tahira Assad Shaikh</creator><creatorcontrib>Madiha Soban ; Iftikhar Ahmed ; Navaid Siddiqui ; Faisal Ahmed ; Ashar fawad ; Tahira Assad Shaikh</creatorcontrib><description><![CDATA[Background: Glutathione (GSH) used for skin lightening can also affect Glucose metabolism in diabetics because of its antioxidant properties. This study aimed to determine the effects of systemic glutathione on various parameters in type 2 diabetes. Methods: It was an interventional study (open label trial) conducted at Skin care clinic and Baqai Institute of Diabetes and Endocrinology from August 2019 to January 2020. Total patients included in this study were 46 who met the inclusion criteria along with 20 participants as controls. Oral Glutathione (500 mg B.D) was given to both groups for 18 weeks. Pre and post treatment Plasma Glutathione, fasting blood sugar (FBS), random blood sugar (RBS), and HbA1c levels were evaluated. Taylor hyperpigmentation scale was used to measure skin tone. BMI and Anthropometric measurements were also measured. Paired t-test/dependent t-test and Chi squared test was performed and p < 0.05 was considered statistically significant. Results: Oral Glutathione caused significant reduction in FBS, RBS and HbA1c levels in type 2 diabetics. Mean values of both random and fasting blood sugar significantly decreased in patients group. RBS decreased from 232±10.04 mg/dl to 178±10.37 mg/dl (<0.001*), whereas FBS decreased from 136±10.42mg/dl to 129.24±102.78 mg/dl (<0.002*). HbA1c was significantly decreased in patients group from 7.72 ± 2.04 to 6.66 ± 1.37 (<0.001). Weight, BMI, and systolic blood sugar were also decreased in both groups p=< 0.05, <0.05, 0.005 respectively. Conclusion: Systemic glutathione used for skin tone lightening in diabetics caused significant reduction in FBS, RBS and HBA1c levels. Glutathione can be used as an adjuvant therapy in diabetics. Keywords: Diabetes Mellitus; Glutathione; Skin Pigmentation.]]></description><identifier>ISSN: 2313-7371</identifier><identifier>EISSN: 2308-2593</identifier><identifier>DOI: 10.36283/PJMD10-4/004</identifier><language>eng</language><publisher>ziauddin University</publisher><ispartof>Pakistan journal of medicine and dentistry, 2024-05, Vol.10 (4)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,2096,27900,27901</link.rule.ids></links><search><creatorcontrib>Madiha Soban</creatorcontrib><creatorcontrib>Iftikhar Ahmed</creatorcontrib><creatorcontrib>Navaid Siddiqui</creatorcontrib><creatorcontrib>Faisal Ahmed</creatorcontrib><creatorcontrib>Ashar fawad</creatorcontrib><creatorcontrib>Tahira Assad Shaikh</creatorcontrib><title>The Effect of Glutathione as an Adjuvant Therapy for Skin Whitening and Hyperpigmentation in Type 2 Diabetes</title><title>Pakistan journal of medicine and dentistry</title><description><![CDATA[Background: Glutathione (GSH) used for skin lightening can also affect Glucose metabolism in diabetics because of its antioxidant properties. This study aimed to determine the effects of systemic glutathione on various parameters in type 2 diabetes. Methods: It was an interventional study (open label trial) conducted at Skin care clinic and Baqai Institute of Diabetes and Endocrinology from August 2019 to January 2020. Total patients included in this study were 46 who met the inclusion criteria along with 20 participants as controls. Oral Glutathione (500 mg B.D) was given to both groups for 18 weeks. Pre and post treatment Plasma Glutathione, fasting blood sugar (FBS), random blood sugar (RBS), and HbA1c levels were evaluated. Taylor hyperpigmentation scale was used to measure skin tone. BMI and Anthropometric measurements were also measured. Paired t-test/dependent t-test and Chi squared test was performed and p < 0.05 was considered statistically significant. Results: Oral Glutathione caused significant reduction in FBS, RBS and HbA1c levels in type 2 diabetics. Mean values of both random and fasting blood sugar significantly decreased in patients group. RBS decreased from 232±10.04 mg/dl to 178±10.37 mg/dl (<0.001*), whereas FBS decreased from 136±10.42mg/dl to 129.24±102.78 mg/dl (<0.002*). HbA1c was significantly decreased in patients group from 7.72 ± 2.04 to 6.66 ± 1.37 (<0.001). Weight, BMI, and systolic blood sugar were also decreased in both groups p=< 0.05, <0.05, 0.005 respectively. Conclusion: Systemic glutathione used for skin tone lightening in diabetics caused significant reduction in FBS, RBS and HBA1c levels. Glutathione can be used as an adjuvant therapy in diabetics. Keywords: Diabetes Mellitus; Glutathione; Skin Pigmentation.]]></description><issn>2313-7371</issn><issn>2308-2593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kE9LAzEQxRdRsGiP3vMF1k42f3Z7LG2tiqJgxWOYbCZtartbsqvQb29sxdM8Ho_fY16W3XC4FbqoxOj18XnGIZcjAHmWDQoBVV6osTj_1VzkpSj5ZTbsug0ACAFlJfQg2y7XxObeU92z1rPF9qvHfh3ahhh2DBs2cZuvb2x6loIR9wfm28jePkPDPtahpyY0qxRz7P6wp7gPqx01iZAALEWWyWQFmwW01FN3nV143HY0_LtX2fvdfDm9z59eFg_TyVNecylkrgBIK-tUYQutJFRE1gG3WCqucFyhJo2uAueV1l5VpU0PAtkxjLV0WIir7OHEdS1uzD6GHcaDaTGYo9HGlcHYh3pLphaWewBXpgJZe4s89aDSlSJZeOcSKz-x6th2XST_z-Ngjsub0_JGmrS8-AFCe3Yp</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Madiha Soban</creator><creator>Iftikhar Ahmed</creator><creator>Navaid Siddiqui</creator><creator>Faisal Ahmed</creator><creator>Ashar fawad</creator><creator>Tahira Assad Shaikh</creator><general>ziauddin University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>20240501</creationdate><title>The Effect of Glutathione as an Adjuvant Therapy for Skin Whitening and Hyperpigmentation in Type 2 Diabetes</title><author>Madiha Soban ; Iftikhar Ahmed ; Navaid Siddiqui ; Faisal Ahmed ; Ashar fawad ; Tahira Assad Shaikh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1434-500e65bd52b265408eebd01ba7515a98a6e6ad80df566f587b2310eb90964da23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Madiha Soban</creatorcontrib><creatorcontrib>Iftikhar Ahmed</creatorcontrib><creatorcontrib>Navaid Siddiqui</creatorcontrib><creatorcontrib>Faisal Ahmed</creatorcontrib><creatorcontrib>Ashar fawad</creatorcontrib><creatorcontrib>Tahira Assad Shaikh</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pakistan journal of medicine and dentistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Madiha Soban</au><au>Iftikhar Ahmed</au><au>Navaid Siddiqui</au><au>Faisal Ahmed</au><au>Ashar fawad</au><au>Tahira Assad Shaikh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effect of Glutathione as an Adjuvant Therapy for Skin Whitening and Hyperpigmentation in Type 2 Diabetes</atitle><jtitle>Pakistan journal of medicine and dentistry</jtitle><date>2024-05-01</date><risdate>2024</risdate><volume>10</volume><issue>4</issue><issn>2313-7371</issn><eissn>2308-2593</eissn><abstract><![CDATA[Background: Glutathione (GSH) used for skin lightening can also affect Glucose metabolism in diabetics because of its antioxidant properties. This study aimed to determine the effects of systemic glutathione on various parameters in type 2 diabetes. Methods: It was an interventional study (open label trial) conducted at Skin care clinic and Baqai Institute of Diabetes and Endocrinology from August 2019 to January 2020. Total patients included in this study were 46 who met the inclusion criteria along with 20 participants as controls. Oral Glutathione (500 mg B.D) was given to both groups for 18 weeks. Pre and post treatment Plasma Glutathione, fasting blood sugar (FBS), random blood sugar (RBS), and HbA1c levels were evaluated. Taylor hyperpigmentation scale was used to measure skin tone. BMI and Anthropometric measurements were also measured. Paired t-test/dependent t-test and Chi squared test was performed and p < 0.05 was considered statistically significant. Results: Oral Glutathione caused significant reduction in FBS, RBS and HbA1c levels in type 2 diabetics. Mean values of both random and fasting blood sugar significantly decreased in patients group. RBS decreased from 232±10.04 mg/dl to 178±10.37 mg/dl (<0.001*), whereas FBS decreased from 136±10.42mg/dl to 129.24±102.78 mg/dl (<0.002*). HbA1c was significantly decreased in patients group from 7.72 ± 2.04 to 6.66 ± 1.37 (<0.001). Weight, BMI, and systolic blood sugar were also decreased in both groups p=< 0.05, <0.05, 0.005 respectively. Conclusion: Systemic glutathione used for skin tone lightening in diabetics caused significant reduction in FBS, RBS and HBA1c levels. Glutathione can be used as an adjuvant therapy in diabetics. Keywords: Diabetes Mellitus; Glutathione; Skin Pigmentation.]]></abstract><pub>ziauddin University</pub><doi>10.36283/PJMD10-4/004</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2313-7371
ispartof Pakistan journal of medicine and dentistry, 2024-05, Vol.10 (4)
issn 2313-7371
2308-2593
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c3b1f00d7d014cfba11baa5685e42fdd
source DOAJ Directory of Open Access Journals
title The Effect of Glutathione as an Adjuvant Therapy for Skin Whitening and Hyperpigmentation in Type 2 Diabetes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T12%3A34%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effect%20of%20Glutathione%20as%20an%20Adjuvant%20Therapy%20for%20Skin%20Whitening%20and%20Hyperpigmentation%20in%20Type%202%20Diabetes&rft.jtitle=Pakistan%20journal%20of%20medicine%20and%20dentistry&rft.au=Madiha%20Soban&rft.date=2024-05-01&rft.volume=10&rft.issue=4&rft.issn=2313-7371&rft.eissn=2308-2593&rft_id=info:doi/10.36283/PJMD10-4/004&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_c3b1f00d7d014cfba11baa5685e42fdd%3C/doaj_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1434-500e65bd52b265408eebd01ba7515a98a6e6ad80df566f587b2310eb90964da23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true